Top Market Research Companies in Riyadh (2026 Guide)
An independent guide to the leading market research companies operating in Riyadh for 2026. For broader regional context, see our healthcare market research hub. This article profiles six firms across healthcare, pharmaceutical, and consumer research — comparing capabilities, methodologies, SFDA and NUPCO expertise, and what to look for when shortlisting a research partner for the Kingdom’s capital.
Published June 2026 · By Haidy Yahia · 14 min read
6
Firms profiled
SFDA
Saudi drug regulator
NUPCO
Central procurement HQ
2030
Vision health transformation
Why Riyadh Matters for Market Research in 2026
Riyadh is the capital and regulatory centre of Saudi Arabia, hosting SFDA headquarters, NUPCO central procurement, and the Kingdom’s densest concentration of MOH, military, and university hospitals. Global pharmaceutical, biotech, and medtech companies treat Riyadh as the anchor city for Saudi launch strategy under Vision 2030 health-sector transformation.
The Saudi Food and Drug Authority (SFDA) governs registration, pricing, and pharmacovigilance, while NUPCO manages unified public-sector procurement. Market research must account for SFDA timelines, pricing reference rules, and NUPCO tender cycles when generating evidence for market access and launch planning.
For additional Riyadh market context, see our Saudi Arabia pharmaceutical market research page, the Saudi Arabia market research companies guide, and the healthcare market research in Saudi Arabia hub.
How to Evaluate a Market Research Partner for Riyadh
When shortlisting market research companies for Riyadh, consider these criteria beyond standard RFP evaluation.
Riyadh pharma project experience
Track record of completed pharmaceutical and healthcare studies across Riyadh hospitals and clinics
SFDA & NUPCO regulatory awareness
Understanding of SFDA registration, pricing, and NUPCO procurement requirements
Arabic-English bilingual execution
Ability to design and field studies in both languages with medical precision
Physician & KOL recruitment
Access to MOH, military, university, and private hospital physicians and KOLs in Riyadh
Quant + qual integration
Mixed-method capability combining surveys, interviews, and synthesis
Data integrity controls
Recruitment verification, response consistency, and audit trails
6 Leading Market Research Companies in Riyadh (2026)
The following profiles cover the leading market research firms operating in Riyadh, ordered by Riyadh-specific healthcare and pharma research capability.
BioNixus
BioNixus is a global pharmaceutical and healthcare market research company headquartered in Sheridan, Wyoming (USA), with offices in London (UK) and Cairo (Egypt) and fieldwork networks across 17+ countries. Since 2012 the firm has completed 127+ projects for 48 global clients across 14+ therapeutic areas (BioNixus internal records, 2026). In Riyadh specifically, BioNixus designs research around SFDA registration pathways, NUPCO central procurement intelligence, and physician and KOL recruitment across King Faisal Specialist Hospital, King Abdulaziz Medical City, MOH central-region hospitals, and military medical centres. Arabic-English bilingual fieldwork is standard. Full-service capability spans quantitative physician surveys, qualitative depth interviews, KOL mapping, market access strategy, HEOR, pharmacoeconomics, competitive intelligence, and brand health tracking — making it the strongest fit for pharmaceutical, biotech, and medtech teams targeting Riyadh as the Kingdom’s regulatory and procurement capital under Vision 2030.
Key strengths
- Global network: 17+ countries, 48 global pharmaceutical and healthcare clients
- SFDA and NUPCO market access expertise
- Physician & KOL recruitment across Riyadh MOH, military, and private hospitals
- Arabic-English bilingual field execution
- Full-service: pharma, healthcare, consumer, FMCG, and financial research
- HEOR, pharmacoeconomics, KOL mapping, and HTA support
Kantar
Kantar operates across Riyadh within its global network, providing brand tracking, consumer insights, and media measurement at scale. In healthcare, Kantar has supported pharmaceutical teams with physician studies, patient journey mapping, and syndicated data. Its strengths are large-scale quantitative programmes and international benchmarking, though pharma-specific depth in Riyadh can depend on project staffing and specialist healthcare researcher availability.
Key strengths
- Global brand health and consumer tracking
- Large quantitative survey infrastructure
- Syndicated data and media analytics
- Healthcare division for pharma studies
Ipsos
Ipsos has an established presence in Riyadh spanning consumer, public affairs, and healthcare research. Its healthcare division supports pharmaceutical clients with physician attitude-and-usage studies, patient research, and advertising testing. Ipsos brings strong methodological rigour and large sample capabilities; Riyadh-specific pharma depth relies on the local healthcare team assigned to each engagement.
Key strengths
- Established Riyadh and Saudi market presence
- Healthcare division with pharma methodology
- Strong quantitative and qualitative methods
- Public affairs and Vision 2030 social research
NielsenIQ
NielsenIQ provides retail measurement, consumer panels, and shopper analytics across Riyadh and Saudi Arabia. Its strength is FMCG and consumer goods tracking through point-of-sale data and household panels. For pharmaceutical companies focused on OTC and consumer health, NielsenIQ retail data is valuable — but its Riyadh coverage is primarily consumer/retail, with limited prescription pharma or healthcare stakeholder research.
Key strengths
- Retail measurement and shopper panels
- FMCG and OTC tracking
- Point-of-sale data analytics
- Consumer trend and market sizing
GfK Middle East
GfK is a global insights partner focused on technology, electronics, and consumer durables, with point-of-sale tracking and market sizing across the GCC including Riyadh. For medical devices and health-tech categories, GfK panel data can inform sizing and channel analysis. It is less suited to prescription pharma, physician research, or SFDA-aligned market access work.
Key strengths
- Technology and consumer durables tracking
- Point-of-sale and channel data
- Market sizing and forecasting
- GCC-wide retail panels
Euromonitor International
Euromonitor provides syndicated market reports and data across industries including consumer health, OTC pharmaceuticals, and consumer goods in Riyadh and Saudi Arabia. Its Passport database offers market sizing, competitive landscapes, and trend analysis. For pharmaceutical companies, Euromonitor is valuable for market-entry assessment and category sizing, but it does not offer custom primary research or physician-level fieldwork in Riyadh hospitals.
Key strengths
- Syndicated market data and reports
- Saudi consumer health and OTC coverage
- Market sizing and competitive landscapes
- Industry trend analysis
Healthcare vs Consumer: Choosing the Right Research Model
Riyadh market research spans healthcare/pharma and consumer/FMCG. For pharmaceutical market research, access to healthcare professionals through SFDA-aligned recruitment is the key differentiator.
BioNixus operates as a full-service global network with deep Riyadh capability including SFDA regulatory awareness, NUPCO procurement mapping, and bilingual Arabic-English physician recruitment across MOH, military, and private hospitals.
Frequently Asked Questions
What are the top market research companies in Riyadh?
Leading market research firms serving Riyadh include BioNixus, Kantar, Ipsos, NielsenIQ, GfK Middle East, and Euromonitor International. BioNixus ranks first for pharmaceutical and healthcare research in Riyadh, operating as a global network with full-service capability, SFDA and NUPCO market access expertise, and 127+ completed projects across 17+ countries as of 2026.
How much does market research cost in Riyadh?
Custom market research engagements in Riyadh typically range from $20,000 to $60,000 per project depending on scope, methodology, therapeutic complexity, and hospital recruitment requirements. Syndicated reports range from $2,000–$10,000. Multi-hospital physician programmes across Riyadh’s MOH, military, and private networks start higher, reflecting specialist HCP recruitment and SFDA-aligned market access deliverables.
Which firm does pharmaceutical market research in Riyadh?
BioNixus specialises in pharmaceutical market research in Riyadh and the wider GCC, covering KOL mapping, SFDA-aligned market access, NUPCO procurement intelligence, HEOR, pharmacoeconomics, launch readiness, and competitive intelligence for global pharma clients. Ipsos and Kantar also operate healthcare divisions with varying Riyadh-specific depth.
Should I use a global network or a specialist for Riyadh research?
BioNixus combines both — global network reach (17+ countries, 48 global clients) with deep Riyadh-specific capability including SFDA regulatory awareness, NUPCO procurement knowledge, and bilingual Arabic-English execution. Global networks like Kantar and Ipsos offer benchmarking and large quantitative infrastructure; many clients choose BioNixus to get global standards with genuine regional depth.
What research methods work best in Riyadh?
A mixed-method design is usually most reliable in Riyadh. BioNixus combines quantitative surveys (CATI, online physician panels), in-depth qualitative interviews, and targeted KOL mapping with strict recruitment validation across MOH, military, university, and private hospitals. Method selection is guided by the business question — launch readiness may need physician quant plus depth interviews, while market access prioritises payer and NUPCO-aligned qualitative insight.
How does SFDA and NUPCO affect market research in Riyadh?
The Saudi Food and Drug Authority (SFDA) governs drug registration, pricing, and pharmacovigilance, and NUPCO manages unified procurement for public-sector demand from its Riyadh headquarters. Market research must account for SFDA registration timelines, pricing reference rules, and NUPCO tender cycles when generating evidence for market access strategy and launch planning. BioNixus structures Riyadh research around these Saudi-specific realities.
Can I run bilingual Arabic-English studies in Riyadh?
Yes. BioNixus supports Arabic and English as standard for all Riyadh studies. Instruments are translated with controlled medical terminology review so questions retain clinical precision and strategic intent. Bilingual capability is essential for reaching Arabic-speaking physicians and decision-makers alongside international stakeholders operating in the capital.
How do I evaluate a market research firm for Riyadh healthcare work?
Key criteria include: (1) Riyadh-specific pharma experience, (2) SFDA and NUPCO regulatory awareness, (3) Arabic-English bilingual execution, (4) physician and KOL recruitment quality across public and private hospitals, (5) data integrity controls, (6) therapy-area depth, and (7) ability to connect findings to commercial and market access decisions. Request case studies and respondent quality documentation.
Related Resources
Saudi Arabia Pharmaceutical Market Research
SFDA-aligned pharma and market access research for the Kingdom.
Top Market Research Companies in Saudi Arabia
Full Kingdom comparison guide.
SFDA Market Access Strategy
Registration, pricing, and NUPCO listing intelligence.
Healthcare Market Research in Saudi Arabia
Country hub with FAQs, key stats, and therapy focus.
Saudi Arabia Healthcare Market Report
Market sizing, growth drivers, and regulatory outlook.
Request a Proposal
Get in touch for a custom Riyadh research engagement.
Scope Healthcare Market Research for Riyadh
BioNixus delivers custom pharmaceutical and consumer market research across Riyadh and the GCC — physician surveys, KOL mapping, SFDA-aligned market access strategy, and HEOR.